Bayside, New York Clinical Trials

A listing of Bayside, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 403 clinical trials
Automation_Study_81675  

Overview_81675

AutoSite12082
 (9.3 away)
  • 0 views
  • 27 Feb, 2024
  • 1 location
Automation_Study_36010  

Overview_36010

AutoSite12082
 (9.3 away)
  • 0 views
  • 27 Feb, 2024
  • 1 location
Automation_Study_68145  

Overview_68145

AutoSite12082
 (9.3 away)
  • 0 views
  • 27 Feb, 2024
  • 1 location
Automation_Study_46392  

Overview_46392

AutoSite12082
 (9.3 away)
  • 0 views
  • 27 Feb, 2024
  • 1 location
Automation_Study_16619  

Overview_16619

AutoSite12082
 (9.3 away)
  • 0 views
  • 27 Feb, 2024
  • 1 location
Automation_Study_54349  

Overview_54349

AutoSite12082
 (9.3 away)
  • 0 views
  • 27 Feb, 2024
  • 1 location
end date passed (end date passed)

end date passed

“>
 (5.8 away) Contact site
  • 0 views
  • 14 Mar, 2024
  • 1 location
tVNS in Long COVID-19

A prior open label study has shown that transcutaneous vagus nerve stimulation [tVNS] can improve the health of some patients with postacute sequelae of SARS-CoV-2 infection (PASC), severely affected enough to also fulfill criteria for myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS). The purpose of this study is to compare …

Icahn School of Medicine at Mount Sinai
 (8.8 away) Contact site
  • 0 views
  • 05 May, 2025
  • +1 other locations
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

This study is being done to find out if delivering gemcitabine using the ACT-IOP-003 device directly to the area where the tumor is in the pancreas is safe and tolerable.The main questions the study aims to answer are:Is ACT-IOP-003 safe and tolerable when given to patients with nonmetastatic, locally advanced, …

New York Medical and Diagnostic Center
 (6.1 away) Contact site
  • 0 views
  • 21 Mar, 2026
  • +2 other locations
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease

The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).

alzheimer's disease
Weill Cornell Medicine
 (9.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +2 other locations